Showing results (271-280 of 417) with videos related to
Sort By:
Pageof 42
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.Cancer Causes & Control : CCC|April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestryZhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.Human Molecular Genetics|August 2, 2015
Shared genetics underlying epidemiological association between endometriosis and ovarian cancerYi Lu, Gabriel Cuellar-Partida, Jodie N Painter, et al.Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestriesPeh Joo Ho, Christine Kim Yan Loo, Meng Huang Goh, et al.Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.Plos Genetics|April 26, 2008
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristicsMontserrat Garcia-Closas, Per Hall, Heli Nevanlinna, et al.Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.International Journal of Epidemiology|September 6, 2016
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization studyJue-Sheng Ong, Gabriel Cuellar-Partida, Yi Lu, et al.Cancers|November 13, 2025
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 WomenPeh Joo Ho, Christine Kim Yan Loo, Ryan Jak Yang Lim, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variantInge M M Lakeman, Alexandra J van den Broek, Juliën A M Vos, et al.Pageof 42